Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) Return on Equity (2016 - 2025)

Historic Return on Equity for Kyntra Bio (KYNB) over the last 11 years, with Q3 2025 value amounting to 2.23%.

  • Kyntra Bio's Return on Equity fell 22900.0% to 2.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.23%, marking a year-over-year decrease of 22900.0%. This contributed to the annual value of 0.49% for FY2024, which is 1500.0% down from last year.
  • Latest data reveals that Kyntra Bio reported Return on Equity of 2.23% as of Q3 2025, which was down 22900.0% from 0.39% recorded in Q2 2025.
  • Kyntra Bio's 5-year Return on Equity high stood at 8.8% for Q1 2023, and its period low was 23.78% during Q4 2022.
  • For the 5-year period, Kyntra Bio's Return on Equity averaged around 0.98%, with its median value being 0.45% (2024).
  • In the last 5 years, Kyntra Bio's Return on Equity tumbled by -227700bps in 2022 and then skyrocketed by 255700bps in 2023.
  • Quarter analysis of 5 years shows Kyntra Bio's Return on Equity stood at 1.01% in 2021, then plummeted by -2246bps to 23.78% in 2022, then surged by 108bps to 1.79% in 2023, then tumbled by -125bps to 0.45% in 2024, then tumbled by -396bps to 2.23% in 2025.
  • Its Return on Equity was 2.23% in Q3 2025, compared to 0.39% in Q2 2025 and 0.5% in Q1 2025.